# Peptides Are Everywhere. Businesses Are Cashing In.

Page: https://stenobird.com/podcast/the-journal-547598/peptides-are-everywhere-businesses-are-cashing-in
Text version: https://stenobird.com/podcast/the-journal-547598/peptides-are-everywhere-businesses-are-cashing-in.md
Podcast: [The Journal.](https://stenobird.com/podcast/the-journal-547598)
Published: 2026-07-30T20:00:00+00:00
Episode link: https://pdst.fm/e/traffic.megaphone.fm/WSJ6192530670.mp3
Audio file: https://pdst.fm/e/traffic.megaphone.fm/WSJ6192530670.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-journal-547598/episodes/peptides-are-everywhere-businesses-are-cashing-in
Duration seconds: 1234

## Resource

Tickets for our live show in New York are on sale now! Get yours here. Peptides are a huge part of the wellness craze that’s sweeping social media. Demand for restricted peptides has fueled an online gray market for injections promising youth, beauty and strength. Businesses are racing—and taking risks—to get in on the craze. WSJ's Sara Ashley O’Brien explores the burgeoning peptide market and how a recent FDA hearing could signal things are only just getting started. Jessica Mendoza hosts. Further Listening: - Trillion Dollar Shot - The FDA Boss on the Agency's MAHA Makeover Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-journal-547598/episodes/peptides-are-everywhere-businesses-are-cashing-in/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-journal-547598/peptides-are-everywhere-businesses-are-cashing-in.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.